MeSH term
Frequency | Condition_Probility | Blood Pressure | 6 | 0.0 |
Female | 52 | 0.0 |
Heterotrimeric GTP-Binding Proteins/*genetics | 36 | 75.0 |
Humans | 82 | 0.0 |
Male | 58 | 0.0 |
Middle Aged | 40 | 0.0 |
Polymorphism, Genetic | 13 | 0.0 |
Research Support, Non-U.S. Gov't | 53 | 0.0 |
Alleles | 28 | 0.0 |
Genotype | 46 | 0.0 |
Hypertension/*genetics | 8 | 7.0 |
Insulin Resistance/*genetics | 2 | 2.0 |
Obesity/genetics | 5 | 9.0 |
Polymorphism, Single Nucleotide | 3 | 0.0 |
Adult | 44 | 0.0 |
Heterotrimeric GTP-Binding Proteins/*genetics/physiology | 3 | 100.0 |
*Polymorphism, Genetic | 25 | 0.0 |
Gene Frequency | 13 | 0.0 |
Genetic Predisposition to Disease | 9 | 0.0 |
Japan | 5 | 0.0 |
Calmodulin-Binding Proteins/*genetics | 2 | 8.0 |
Case-Control Studies | 13 | 0.0 |
Comparative Study | 16 | 0.0 |
European Continental Ancestry Group/genetics | 3 | 0.0 |
*Genetic Predisposition to Disease | 3 | 0.0 |
Heterotrimeric GTP-Binding Proteins/genetics | 3 | 27.0 |
Incidence | 2 | 0.0 |
*Polymorphism, Single Nucleotide | 3 | 0.0 |
Prevalence | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Risk | 2 | 0.0 |
Echocardiography | 2 | 0.0 |
Homozygote | 6 | 0.0 |
Polymerase Chain Reaction | 10 | 0.0 |
Adolescent | 12 | 0.0 |
Base Sequence | 8 | 0.0 |
Child | 5 | 0.0 |
Child, Preschool | 3 | 0.0 |
Linear Models | 2 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
English Abstract | 4 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
African Continental Ancestry Group/*genetics | 2 | 0.0 |
Asian Continental Ancestry Group/*genetics | 2 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
Genetic Predisposition to Disease/genetics | 5 | 1.0 |
Polymorphism, Genetic/*genetics | 8 | 0.0 |
Protein Subunits | 4 | 1.0 |
GTP-Binding Protein beta Subunits/*genetics | 2 | 100.0 |
Gene Frequency/genetics | 4 | 0.0 |
Severity of Illness Index | 3 | 0.0 |
Statistics | 2 | 0.0 |
African Continental Ancestry Group/genetics | 2 | 0.0 |
Blood Pressure/genetics | 6 | 16.0 |
Heart Rate/genetics | 2 | 33.0 |
Phenotype | 6 | 0.0 |
Aged | 16 | 0.0 |
Aldosterone/blood | 3 | 1.0 |
Alternative Splicing | 5 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
GTP-Binding Proteins/chemistry/*genetics | 4 | 26.0 |
Genetic Screening | 3 | 0.0 |
*Point Mutation | 2 | 0.0 |
Renin/blood | 2 | 0.0 |
*Alleles | 3 | 0.0 |
Body Mass Index | 8 | 0.0 |
DNA/analysis | 2 | 0.0 |
GTP-Binding Proteins/*genetics | 9 | 7.0 |
Asian Continental Ancestry Group/genetics | 3 | 0.0 |
Heterotrimeric GTP-Binding Proteins/genetics/*physiology | 2 | 100.0 |
Polymorphism, Genetic/physiology | 3 | 11.0 |
Polymorphism, Single Nucleotide/*genetics | 4 | 1.0 |
Animals | 9 | 0.0 |
Comorbidity | 3 | 1.0 |
Hand/blood supply | 3 | 33.0 |
Nitric-Oxide Synthase/*genetics | 2 | 2.0 |
Coronary Angiography | 2 | 0.0 |
Heterozygote | 4 | 0.0 |
Cohort Studies | 4 | 0.0 |
Analysis of Variance | 4 | 0.0 |
Hypertension/*genetics/physiopathology | 3 | 12.0 |
Antihypertensive Agents/therapeutic use | 3 | 3.0 |
Chi-Square Distribution | 2 | 0.0 |
Myocardial Infarction/genetics | 2 | 8.0 |
*Variation (Genetics) | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Logistic Models | 3 | 0.0 |
Risk Factors | 7 | 0.0 |
Blood Pressure/*genetics | 3 | 5.0 |
Retrospective Studies | 3 | 0.0 |
Coronary Disease/genetics | 2 | 5.0 |
Germany/epidemiology | 2 | 1.0 |
Protein Conformation | 2 | 0.0 |
Disease Progression | 2 | 0.0 |
Data Interpretation, Statistical | 2 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Health Surveys | 2 | 2.0 |
Aged, 80 and over | 2 | 0.0 |
Cell Line | 2 | 0.0 |
Blood Pressure/drug effects | 2 | 0.0 |
Cross-Over Studies | 2 | 0.0 |
Double-Blind Method | 2 | 0.0 |
Heart Rate/drug effects | 2 | 0.0 |
Signal Transduction | 3 | 0.0 |
Age Factors | 3 | 0.0 |
Protein Subunits/*genetics | 3 | 15.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Protein Subunits/genetics | 2 | 7.0 |
Treatment Outcome | 2 | 0.0 |
Blood Pressure/*drug effects/*genetics | 2 | 40.0 |
Piperazines/*therapeutic use | 2 | 4.0 |
*Alternative Splicing | 2 | 0.0 |
